{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:43:44Z","timestamp":1781009024976,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020149","name":"Consejo Estatal de Ciencia y Tecnolog\u00eda de Jalisco","doi-asserted-by":"publisher","award":["9261-2021"],"award-info":[{"award-number":["9261-2021"]}],"id":[{"id":"10.13039\/100020149","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanfer Salud Animal","award":["9261-2021"],"award-info":[{"award-number":["9261-2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12033-024-01334-z","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T01:51:53Z","timestamp":1732931513000},"page":"4329-4341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design of a Golden Gate Cloning Plasmid for the Generation of a Chimeric Virus-Like Particle-Based Subunit Vaccine Against Porcine Circovirus Type 2"],"prefix":"10.1007","volume":"67","author":[{"given":"Ana del Socorro","family":"Hern\u00e1ndez-Avi\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando","family":"Mendoza-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitlalli D.","family":"Hern\u00e1ndez-Mancillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alberto","family":"Salazar-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Zapata-Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"Camacho-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Comas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Elena","family":"Sarmiento-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"Arellano-Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alberto","family":"Flores-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-3950","authenticated-orcid":false,"given":"Abel","family":"Guti\u00e9rrez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.prevetmed.2013.02.010","volume":"110","author":"P Alarc\u00f3n","year":"2013","unstructured":"Alarc\u00f3n, P., Rushton, J., & Wieland, B. (2013). Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England\u2014An economic disease model. Preventive Veterinary Medicine, 110, 88\u2013102. https:\/\/doi.org\/10.1016\/j.prevetmed.2013.02.010","journal-title":"Preventive Veterinary Medicine"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/104063870701900601","volume":"19","author":"T Opriessnig","year":"2007","unstructured":"Opriessnig, T., Meng, X. J., & Halbur, P. G. (2007). Porcine circovirus type 2 associated disease: Update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. Journal of Veterinary Diagnostic Investigation, 19, 591\u2013615. https:\/\/doi.org\/10.1177\/104063870701900601","journal-title":"Journal of Veterinary Diagnostic Investigation"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/v14092005","volume":"14","author":"J Guo","year":"2022","unstructured":"Guo, J., Hou, L., Zhou, J., Wang, D., Cui, Y., Feng, X., & Liu, J. (2022). Porcine circovirus type 2 vaccines: Commercial application and research advances. Viruses, 14, 2005. https:\/\/doi.org\/10.3390\/v14092005","journal-title":"Viruses"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11262-014-1099-z","volume":"49","author":"Q Lv","year":"2014","unstructured":"Lv, Q., Guo, K., & Zhang, Y. (2014). Current understanding of genomic DNA of porcine circovirus type 2. Virus Genes, 49, 1\u201310. https:\/\/doi.org\/10.1007\/s11262-014-1099-z","journal-title":"Virus Genes"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1099\/0022-1317-81-9-2281","volume":"81","author":"P Nawagitgul","year":"2000","unstructured":"Nawagitgul, P., Morozov, I., Bolin, S. R., Harms, P. A., Sorden, S. D., & Paul, P. S. (2000). Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. Journal of General Virology, 81, 2281\u20132287. https:\/\/doi.org\/10.1099\/0022-1317-81-9-2281","journal-title":"Journal of General Virology"},{"key":"1334_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molimm.2008.10.028","volume":"46","author":"SB Shang","year":"2009","unstructured":"Shang, S. B., Jin, Y. L., Jiang, X. T., Zhou, J. Y., Zhang, X., Xing, G., He, J. L., & Yan, Y. (2009). Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Molecular Immunology, 46, 327\u2013334. https:\/\/doi.org\/10.1016\/j.molimm.2008.10.028","journal-title":"Molecular Immunology"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"e1007562","DOI":"10.1371\/journal.ppat.1007562","volume":"15","author":"X Mo","year":"2019","unstructured":"Mo, X., Li, X., Yin, B., Deng, J., Tian, K., & Yuan, A. (2019). Structural roles of PCV2 capsid protein N terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope. PLoS Pathogens, 15, e1007562. https:\/\/doi.org\/10.1371\/journal.ppat.1007562","journal-title":"PLoS Pathogens"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.vaccine.2007.12.019","volume":"26","author":"M Fort","year":"2008","unstructured":"Fort, M., Sibila, M., Allepuz, A., Mateu, E., Roerink, F., & Segal\u00e9s, J. (2008). Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine, 26, 1063\u20131071. https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.019","journal-title":"Vaccine"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.vaccine.2012.01.008","volume":"30","author":"L Fraile","year":"2012","unstructured":"Fraile, L., Grau-Roma, L., Sarasola, P., Sinovas, N., Nofrar\u00edas, M., L\u00f3pez-Jimenez, R., L\u00f3pez-Soria, S., Sibila, M., & Segal\u00e9s, J. (2012). Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity. Vaccine, 30, 1986\u20131992. https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.008","journal-title":"Vaccine"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1128\/JVI.78.12.6297-6303.2004","volume":"78","author":"M Fenaux","year":"2004","unstructured":"Fenaux, M., Opriessnig, T., Halbur, P. G., Elvinger, F., & Meng, X. J. (2004). A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. Journal of Virology, 78, 6297\u20136303. https:\/\/doi.org\/10.1128\/JVI.78.12.6297-6303.2004","journal-title":"Journal of Virology"},{"key":"1334_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.vetmic.2012.01.024","volume":"158","author":"M Hemann","year":"2012","unstructured":"Hemann, M., Beach, N. M., Meng, X. J., Halbur, P. G., & Opriessnig, T. (2012). Vaccination with inactivated or live-attenuated chimeric PCV1-2 results in decreased viremia in challenge-exposed pigs and may reduce transmission of PCV2. Veterinary Microbiology, 158, 180\u2013186. https:\/\/doi.org\/10.1016\/j.vetmic.2012.01.024","journal-title":"Veterinary Microbiology"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1016\/S0264-410X(03)00503-6","volume":"21","author":"P Blanchard","year":"2003","unstructured":"Blanchard, P., Mah\u00e9, D., Cariolet, R., Keranflec\u2019h, A., Baudouard, M. A., Cordioli, P., Albina, E., & Jestin, A. (2003). Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine, 21, 4565\u20134575. https:\/\/doi.org\/10.1016\/S0264-410X(03)00503-6","journal-title":"Vaccine"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1016\/j.vaccine.2009.04.028","volume":"27","author":"M Fort","year":"2009","unstructured":"Fort, M., Sibila, M., P\u00e9rez-Mart\u00edn, E., Nofrar\u00edas, M., Mateu, E., & Segal\u00e9s, J. (2009). One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine, 27, 4031\u20134037. https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.028","journal-title":"Vaccine"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.vaccine.2010.10.050","volume":"29","author":"NM Beach","year":"2010","unstructured":"Beach, N. M., Ramamoorthy, S., Opriessnig, T., Wu, S. Q., & Meng, X. J. (2010). Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs. Vaccine, 29, 221\u2013232. https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.050","journal-title":"Vaccine"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/1348-0421.12158","volume":"58","author":"S Sylla","year":"2014","unstructured":"Sylla, S., Cong, Y. L., Sun, Y. X., Yang, G. L., Ding, X. M., Yang, Z. Q., Zhou, Y. L., Yang, M., Wang, C. F., & Ding, Z. (2014). Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice. Microbiology and Immunology, 58, 398\u2013408. https:\/\/doi.org\/10.1111\/1348-0421.12158","journal-title":"Microbiology and Immunology"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1016\/j.vaccine.2010.07.047","volume":"28","author":"S Hayes","year":"2010","unstructured":"Hayes, S., Gamage, L. N. A., & Hayes, C. (2010). Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2). Vaccine, 28, 6789\u20136799. https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.047","journal-title":"Vaccine"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00253-012-4015-2","volume":"95","author":"PC Wu","year":"2012","unstructured":"Wu, P. C., Lin, W. L., Wu, C. M., Chi, J. N., Chien, M. S., & Huang, C. (2012). Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Applied Microbiology and Biotechnology, 95, 1501\u20131507. https:\/\/doi.org\/10.1007\/s00253-012-4015-2","journal-title":"Applied Microbiology and Biotechnology"},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jbiotec.2014.04.006","volume":"181","author":"JN Chi","year":"2014","unstructured":"Chi, J. N., Wu, C. Y., Chien, M. S., Wu, P. C., Wu, C. M., & Huang, C. (2014). The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development. Journal of Biotechnology, 181, 12\u201319. https:\/\/doi.org\/10.1016\/j.jbiotec.2014.04.006","journal-title":"Journal of Biotechnology"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1016\/j.vaccine.2020.03.060","volume":"38","author":"Y Li","year":"2020","unstructured":"Li, Y., Lin, Y., Xin, G., Zhou, X., Lu, H., Zhang, X., Xia, X., & Sun, H. (2020). Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge. Vaccine, 38, 3952\u20133959. https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.060","journal-title":"Vaccine"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.vetmic.2014.03.018","volume":"171","author":"HX Lin","year":"2014","unstructured":"Lin, H. X., Ma, Z., Yang, X. Q., Fan, H. J., & Lu, C. P. (2014). A novel vaccine against porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection. Veterinary Microbiology, 171, 198\u2013205. https:\/\/doi.org\/10.1016\/j.vetmic.2014.03.018","journal-title":"Veterinary Microbiology"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"e52688","DOI":"10.1371\/journal.pone.0052688","volume":"7","author":"\u00c1 Gell\u00e9rt","year":"2012","unstructured":"Gell\u00e9rt, \u00c1., Sal\u00e1nki, K., Tomb\u00e1cz, K., Tuboly, T., & Bal\u00e1zs, E. (2012). A cucumber mosaic virus based expression system for the production of porcine circovirus specific vaccines. PLoS ONE, 7, e52688. https:\/\/doi.org\/10.1371\/journal.pone.0052688","journal-title":"PLoS ONE"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/bab.1491","volume":"64","author":"BE Aguilera","year":"2017","unstructured":"Aguilera, B. E., Ch\u00e1vez, G., Elizondo, D., Jimenez, M. N., Carrillo, M., Silva, L., Hern\u00e1ndez, R., & Guti\u00e9rrez-Ortega, A. (2017). Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus\u2013like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative. Biotechnology and Applied Biochemistry, 64, 406\u2013414. https:\/\/doi.org\/10.1002\/bab.1491","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"e3647","DOI":"10.1371\/journal.pone.0003647","volume":"3","author":"C Engler","year":"2008","unstructured":"Engler, C., Kandzia, R., & Marillonnet, S. (2008). A one pot, one step, precision cloning method with high throughput capability. PLoS ONE, 3, e3647. https:\/\/doi.org\/10.1371\/journal.pone.0003647","journal-title":"PLoS ONE"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"e0189892","DOI":"10.1371\/journal.pone.0189892","volume":"13","author":"AI Andreou","year":"2018","unstructured":"Andreou, A. I., & Nakayama, N. (2018). Mobius assembly: A versatile golden-gate framework towards universal DNA assembly. PLoS ONE, 13, e0189892. https:\/\/doi.org\/10.1371\/journal.pone.0189892","journal-title":"PLoS ONE"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12918-017-0492-3","volume":"11","author":"R Prielhofer","year":"2017","unstructured":"Prielhofer, R., Barrero, J. J., Steuer, S., Gassler, T., Zahrl, R., Baumann, K., Sauer, M., Mattanovich, D., Gasser, B., & Marx, H. (2017). GoldenPiCS: A Golden Gate-derived modular cloning system for applied synthetic biology in the yeast Pichia pastoris. BMC Systems Biology, 11, 123. https:\/\/doi.org\/10.1186\/s12918-017-0492-3","journal-title":"BMC Systems Biology"},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/nar\/28.1.292","volume":"28","author":"Y Nakamura","year":"2000","unstructured":"Nakamura, Y., Gojobori, T., & Ikemura, T. (2000). Codon usage tabulated from international DNA sequence databases: Status for the year 2000. Nucleic Acids Research, 28, 292. https:\/\/doi.org\/10.1093\/nar\/28.1.292","journal-title":"Nucleic Acids Research"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey, A., Di Canzio, J., & Zurakowski, D. (1998). A statistically defined endpoint titer determination method for immunoassays. Journal of Immunol. Methods, 221, 35\u201341. https:\/\/doi.org\/10.1016\/s0022-1759(98)00170-7","journal-title":"Journal of Immunol. Methods"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"790121","DOI":"10.3389\/fmicb.2021.790121","volume":"12","author":"H Tariq","year":"2022","unstructured":"Tariq, H., Batool, S., Asif, S., Ali, M., & Abbasi, B. H. (2022). Virus-like particles: Revolutionary platforms for developing vaccines against emerging infectious diseases. Frontiers in Microbiology, 12, 790121. https:\/\/doi.org\/10.3389\/fmicb.2021.790121","journal-title":"Frontiers in Microbiology"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"19851","DOI":"10.1038\/s41598-021-98706-1","volume":"11","author":"K Hashemi","year":"2021","unstructured":"Hashemi, K., Ghahramani, M., Ahmadian, M. R., Bizhan, M. N., Reza, M., Dehghani, H., & Afkhami, A. (2021). Optimizing the synthesis and purification of MS2 virus like particles. Science and Reports, 11, 19851. https:\/\/doi.org\/10.1038\/s41598-021-98706-1","journal-title":"Science and Reports"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jviromet.2012.01.003","volume":"181","author":"T Koho","year":"2012","unstructured":"Koho, T., M\u00e4ntyl\u00e4, T., Laurinm\u00e4ki, P., Huhti, L., Butcher, S. J., Vesikari, T., Kulomaa, M. S., & Hyt\u00f6nen, V. P. (2012). Purification of norovirus-like particles (VLPs) by ion exchange chromatography. Journal of Virological Methods, 181, 6\u201311. https:\/\/doi.org\/10.1016\/j.jviromet.2012.01.003","journal-title":"Journal of Virological Methods"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fbioe.2020.00395","volume":"8","author":"P Vormittag","year":"2020","unstructured":"Vormittag, P., Klamp, T., & Hubbuch, J. (2020). Ensembles of hydrophobicity scales as potent classifiers for chimeric virus-like particle solubility\u2014An amino acid sequence-based machine learning approach. Frontiers in Bioengineering and Biotechnology, 8, 395. https:\/\/doi.org\/10.3389\/fbioe.2020.00395","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3389\/fbioe.2020.00881","volume":"8","author":"P Vormittag","year":"2020","unstructured":"Vormittag, P., Klamp, T., & Hubbuch, J. (2020). Optimization of a soft ensemble vote classifier for the prediction of chimeric virus-like particle solubility and other biophysical properties. Frontiers in Bioengineering and Biotechnology, 8, 881. https:\/\/doi.org\/10.3389\/fbioe.2020.00881","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.bbrc.2003.11.055","volume":"312","author":"K Tsumoto","year":"2003","unstructured":"Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., & Arakawa, T. (2003). Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochemical and Biophysical Research Communications, 312, 1383\u20131386. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.055","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1334_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1021\/bp0498793","volume":"20","author":"K Tsumoto","year":"2004","unstructured":"Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., Philo, J. S., & Arakawa, T. (2004). Role of arginine in protein refolding, solubilization, and purification. Biotechnology Progress, 20, 1301\u20131308. https:\/\/doi.org\/10.1021\/bp0498793","journal-title":"Biotechnology Progress"},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"18631","DOI":"10.1038\/s41598-019-54928-y","volume":"9","author":"DT Le","year":"2019","unstructured":"Le, D. T., Radukic, M. T., & M\u00fcller, K. M. (2019). Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly. Science and Reports, 9, 18631. https:\/\/doi.org\/10.1038\/s41598-019-54928-y","journal-title":"Science and Reports"},{"key":"1334_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jbiotec.2015.12.018","volume":"219","author":"C Ladd","year":"2016","unstructured":"Ladd, C., Baumann, P., Weigel, C., Vormittag, P., Middelberg, A., & Hubbuch, J. (2016). High-throughput process development of an alternative platform for the production of virus-like particles in Escherichia coli. Journal of Biotechnology, 219, 7\u201319. https:\/\/doi.org\/10.1016\/j.jbiotec.2015.12.018","journal-title":"Journal of Biotechnology"},{"key":"1334_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jbiotec.2010.08.010","volume":"150","author":"MWO Liew","year":"2010","unstructured":"Liew, M. W. O., Rajendran, A., & Middelberg, A. P. J. (2010). Microbial production of virus-like particle vaccine protein at gram-per-litre levels. Journal of Biotechnology, 150, 224\u2013231. https:\/\/doi.org\/10.1016\/j.jbiotec.2010.08.010","journal-title":"Journal of Biotechnology"},{"key":"1334_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jbiotec.2016.01.017","volume":"220","author":"PC Wu","year":"2016","unstructured":"Wu, P. C., Chen, T. Y., Chin, J. N., Chien, M. S., & Huang, C. (2016). Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli. Journal of Biotechnology, 220, 78\u201385. https:\/\/doi.org\/10.1016\/j.jbiotec.2016.01.017","journal-title":"Journal of Biotechnology"},{"key":"1334_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fbp.2021.10.001","volume":"131","author":"AR Peswani","year":"2022","unstructured":"Peswani, A. R., Narkpuk, J., Krueger, A., Bracewell, D. G., Lekcharoensuk, P., Haslam, S. M., Dell, A., Jaru-Ampornpan, P., & Robinson, C. (2022). Novel constructs and one-step chromatography protocols for the production of porcine circovirus 2d (PCV2d) and circovirus 3 (PCV3) subunit vaccine candidates. Food and Bioproducts Processing, 131, 125\u2013135. https:\/\/doi.org\/10.1016\/j.fbp.2021.10.001","journal-title":"Food and Bioproducts Processing"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/vaccines11010169","volume":"11","author":"S Noppiboon","year":"2023","unstructured":"Noppiboon, S., Lapanusorn, N., Ekkpongpaisit, P., Slack, S., Frank, S., & Hocharoen, L. (2023). A simple and cost-efficient platform for a novel porcine circovirus type 2d (PCV2d) vaccine manufacturing. Vaccines, 11, 169. https:\/\/doi.org\/10.3390\/vaccines11010169","journal-title":"Vaccines"},{"key":"1334_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5483\/bmbrep.2006.39.1.016","volume":"39","author":"S Chatchen","year":"2005","unstructured":"Chatchen, S., Jur\u00edsek, M., Rueda, P., & Kertbundit, S. (2005). Papaya ringspot virus coat protein gene for antigen presentation in Escherichia coli. Journal of Biochemistry and Molecular Biology, 39, 16\u201321. https:\/\/doi.org\/10.5483\/bmbrep.2006.39.1.016","journal-title":"Journal of Biochemistry and Molecular Biology"},{"key":"1334_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","volume":"194","author":"C Chae","year":"2012","unstructured":"Chae, C. (2012). Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application. The Veterinary Journal, 194, 151\u2013157. https:\/\/doi.org\/10.1016\/j.tvjl.2012.06.031","journal-title":"The Veterinary Journal"},{"key":"1334_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0014-5793(98)00429-3","volume":"427","author":"MR Fernandez-Fernandez","year":"1998","unstructured":"Fernandez-Fernandez, M. R., Martinez-Torrecuadrada, J. L., Casal, J. I., & Garcia, J. A. (1998). Development of an antigen presentation system based on plum pox potyvirus. FEBS Letters, 427, 229\u2013235. https:\/\/doi.org\/10.1016\/S0014-5793(98)00429-3","journal-title":"FEBS Letters"},{"key":"1334_CR44","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/jvi.77.6.3487-3494.2003","volume":"77","author":"M Saini","year":"2003","unstructured":"Saini, M., & Vrati, S. (2003). A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge. Journal of Virology, 77, 3487\u20133494. https:\/\/doi.org\/10.1128\/jvi.77.6.3487-3494.2003","journal-title":"Journal of Virology"},{"key":"1334_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12033-011-9480-9","volume":"52","author":"I Kalnciema","year":"2012","unstructured":"Kalnciema, I., Skrastina, D., Ose, V., Pumpens, P., & Zeltins, A. (2012). Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches. Molecular Biotechnology, 52, 129\u2013139. https:\/\/doi.org\/10.1007\/s12033-011-9480-9","journal-title":"Molecular Biotechnology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01334-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:18:00Z","timestamp":1761711480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01334-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01334-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol was approved by the Internal Committee for Care and Use of Laboratory Animals (protocol: CICUAL-2023-001A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Participants"}}]}}